Drug Shortage Report for JAMP-RISEDRONATE

Last updated on 2021-04-07 History
Report ID 137087
Drug Identification Number 02368552
Brand name JAMP-RISEDRONATE
Common or Proper name Risedronate
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) RISEDRONATE SODIUM
Strength(s) 35MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 4
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-11-01
Estimated end date 2022-12-30
Actual end date
Shortage status Actual shortage
Updated date 2021-04-07
Company comments Supply Issues
Health Canada comments
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-04-07 French Compare
v1 2021-04-07 English Compare